European Journal of Clinical Pharmacology

, Volume 74, Issue 5, pp 673–674 | Cite as

Answering letter to remark of Dr’s Frank and Fitzgerald

  • Günther Krumpl
Letter to the Editor


  1. 1.
    Reilly CS, Wood M, Koshakji RP, Wood AJ (1985) Ultra-short-acting beta-blockade: a comparison with conventional beta-blockade. Clin Pharmacol Ther 38:579–585Google Scholar
  2. 2.
    Menkhaus PG, Reves JG, Kissin I, Alvis JM, Govier AV, Samuelson PN, Lell WA, Henling CE, Bradley E (1985) Cardiovascular effects of esmolol in anesthetized humans. Anest Analg 64:327–334Google Scholar
  3. 3.
    Iskandrian AS, Bemis CE, Hakki AH, Panidis I, Heo J, Toole JG, Hua TA, Allin D, Kane-Marsch S (1986) Effects of esmolol on patients with left ventricular dysfunction. JACC 8:225–231Google Scholar
  4. 4.
    Zsigmond EK, Barabas E, Korenaga GM (1988) Esmolol attenuates tachycardia caused by tracheal intubation: a double-blind study. Int J Clin Pharmacol 26(5):225–231Google Scholar
  5. 5.
    Whirley-Diaz J, Gold MI, Helfman SM, deLisser EA (1991) Can esmolol manage surgically-induced tachycardia? Bolus esmolol treatment of intra-operative tachycardia due to surgical stimulation. Anaesthesia 46:220–223Google Scholar
  6. 6.
    Miller DR, Martineau RJ, Wynands JE; Hill J (1991) Bolus administration of esmolol for controlling the haemodynamic response to tracheal intubation: the Canadian Multicentre Trial. Can J Anesthesia 38(7):849–858Google Scholar
  7. 7.
    Deegan R, Wood AJ (1994) Beta-receptor antagonism does not fully explain esmolol-induced hypotension. Clin Pharmacol Ther 56:223–228Google Scholar
  8. 8.
    Felix SB, Stangl V, Kieback A, Dörffel W, Staudt A, Wernekce KD, Baumann G, Stangl K (2001) Acute hemodynamic effecst of beta-blockers in patients with severe congestive heart failure: comparison of celiprolol and esmolol. J Cardiovasc Pharmacol 38(5):666–671Google Scholar
  9. 9.
    Tanahashi S, Lida H, Dohi S, Oda A, Osawa Y, Yamaguchi S (2008) Comparative effects of ultra-shortacting beta1-blockers on voltage-gated tetrodotoxin-resistant Na+ channels in rat sensory neurons. Europ J Anesthesiol 26:196–200Google Scholar
  10. 10.
    Sugiyama A, Takahara A, Hashimoto K (1999) Electrophysiologic, cardiohemodynamic and betablocking actions of a new ultra-short-acting beta-blocker, ONO-1101, assessed by the in vivo canine model in comparison with esmolol. J Cardiovasc Pharmacol 24:70–77Google Scholar
  11. 11.
    Shibata S, Okamoto Y, Endo S, Ono K (2012) Direct effects of esmolol and landiolol on cardiac function, coronary vasoactivity, and ventricular electrophysiology in guinea-pig hearts. J Pharmacol Sci 118:225–265Google Scholar
  12. 12.
    Kakuta N, Kawano T, Tanaka K, and Oshita S (2005) A comparison of landiolol and esmolol for attenuation of cardiovascular response and plasma renin activity against tracheal intubation with laryngoscopy. Anesthesiology 103:A433Google Scholar
  13. 13.
    Yamakage M, Iwasaki S, Jeong SW, Satoh J, Namiki A (2009) Beta-1 selective adrenergic antagonist landiolol and esmolol can be safely used in patients with airway hyperreactivity. Heart Lung 38(1):48–55Google Scholar
  14. 14.
    Xiao J, Ping H, Zou Q, Zhao Y, Xue Z, Deng X, Li S, Guo Q, Tao G, Yang T, Lang Z, He J, Wang X (2015) Landiolol in the treatment of the intraoperative supraventricular tachycardia: a multicenter, randomized, double-blind, placebo-controlled study. J Clin Anesth 27(2):120–129Google Scholar
  15. 15.
    Yang X, Li S (2016) Analysis of esmolol and landiolol on elderly patients in the perioperative period with gastric surgery. Int J Clin Exp Pathol 9(12):12755–12760Google Scholar
  16. 16.
    Oda Y, Nishikawa K, Hase I, Asada A (2005) The short-acting beta1-adrenoceptor antagonists esmolol and landiolol suppress the bispectral index response to tracheal intubation during sevoflurane anesthesia. Anesth Analg 100:733–737Google Scholar
  17. 17.
    Krumpl G, Ulč I, Trebs M, Kadlecová P, Hodisch J, Maurer G, Husch B (2017) Pharmacokinetics and - dynamics of low, intermediate and high dose landiolol and esmolol during long term infusion in healthy Caucasians. J Cardiovasc Pharmacol.
  18. 18.
    Inoue S, Abe R, Kawaguchi M, Kobayashi H, Furuya H (2010) Beta blocker infusion decreases the magnitude of core hypothermia after anesthesia induction. Minerva Anesthesiologica 76(12):1002–1009Google Scholar
  19. 19.
    Li L, Ai Q, Lin L, Ge P, Yang C, Zhang L (2015) Efficacy and safety of landiolol for prevention of atrial fibrillation after cardiac surgery: a meta-analysis of randomized controlled trials. Int J Clin Exp Med 8(7):10265–10273Google Scholar
  20. 20.
    Nagai R, Kinugawa K, Inoue H, Atarashi H, Seino Y, Yamashita T, Shimizu W, Aiba T, Kitakaze M, Sakamoto A (2013) Urgent management of rapid heart rate in patients with atrial fibrillation/flutter and left ventricular dysfunction: comparison of the ultra-short-acting Beta1-selective blocker landiolol with digoxin (J-Land Study). Circ J 77(4):908–916Google Scholar
  21. 21.
    Harwood TN, Butterworth J, Prielipp RC, Royster RL, Hansen K, Plonk G, Dean R (1999) The safety and effectiveness of esmolol in the perioperative period in patients undergoing abdominal aortic surgery. J Cardiothorac Vasc Anesth 13(5):555–561Google Scholar
  22. 22.
    Kurian SM, Evans R, Fernandes NO, Sherry KM (2001) The effect of an infusion of esmolol on the incidence of myocardial ischaemia during tracheal extubation following coronary artery surgery. Anaesthesia 56(12):1163–1168Google Scholar
  23. 23.
    Balcetyte-Harris N, Tamis JE, Homel P, Menchavez E, Steinberg J (2002) Randomized study of early intravenous esmolol versus oral beta-blockers in preventing post-CABG atrial fibrillation in high risk patients identified by signal-averaged ECG: results of a pilot study. Ann Noninvasive Electrocardiol 7(2):86–91Google Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.MRN Medical Research Network GmbHViennaAustria

Personalised recommendations